PCA
ETON icon

Prospect Capital Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Prospect Capital Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69M Buy
+157,200
New +$4.61M 2.58% 16

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Prospect Capital Advisors's ETON Position: Q2 2026 in Review

Prospect Capital Advisors opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 157,200 shares worth $5.69M. The stake represents 2.58% of the portfolio and ranks #16 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Prospect Capital Advisors held 157,200 shares of Eton Pharmaceutcials worth $5.69M as of Q2 2026.
  • Eton Pharmaceutcials was a new Prospect Capital Advisors position in Q2 2026.
  • Eton Pharmaceutcials made up 2.58% of Prospect Capital Advisors's portfolio in Q2 2026, its #16 holding.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Prospect Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.